References
- Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med.345, 1359–1367 (2001).
- Szabo C, Biser A, Benko R, Bottinger E, Susztak K. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of Type 2 diabetic Leprdb/db mice. Diabetes55, 3004–3012 (2006).
- Ceriello A. Oxidative stress and diabetes-associated complications. Endocr. Pract.12, 60–62 (2006).
- Corstjens AM, van der Horst IC, Zijlstra JG et al. Hyperglycaemia in critically ill patients: marker or mediator of mortality? Crit. Care10, 216 (2006).
- Preiser JC. Restoring normoglycemia: not so harmless. Crit. Care12, 116 (2008).
- Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N. Engl. J. Med.354, 449–461 (2006).
- Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin. Proc.79, 992–1000 (2004).
- Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA290, 2041–2047 (2003).
- Gabbanelli V, Pantanetti S, Donati A, Principi T, Pelaia P. Correlation between hyperglycemia and mortality in a medical and surgical intensive care unit. Minerva Anestesiol.71, 717–725 (2005).
- Devos P, Preiser JC, Mélot C; on behalf of the Glucontrol Steering Committee. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med.33, S189 (2007).
- Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am. J. Crit. Care15, 370–377 (2006).
- McMullin J, Brozek J, Jaeschke R et al. Glycemic control in the ICU: a multicenter survey. Intensive Care Med.30, 798–803 (2004).
- Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N. Engl. J. Med.358, 125–139 (2008).
- Preiser JC, Sottiaux T; on behalf of the Belgian Federal Board for Intensive Care. Tight glucose by intensive insulin therapy in Belgian intensive care units: an evaluation of practice. Acta Gastroenterol. Belg.71, N01 (2008).
- Devos P, Ledoux D, Preiser JC. Current practice of glycaemia control in European intensive care units (ICUS). Intensive Care Med.31, S203 (2005).
- Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology105, 244–252 (2006).
- Monnier L, Mas E, Ginet C et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with Type 2 diabetes. JAMA295, 1681–1687 (2006).
- Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J. Diabetes Complications19, 178–181 (2005).
- Ali N, O’Brien J, Dungan K et al. Glucose variability and mortality in patients with sepsis. Crit. Care Med. (In press).
- Preiser JC, Devos P. Steps for the implementation and validation of tight glucose control Intensive Care Med.33, 570–571 (2007).
- Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit. Care10, R19 (2006).
- Van den Berghe G, Wilmer A, Milants I et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes55, 3151–3159 (2006).
- Devos P, Chiolero R, Van den Berghe G, Preiser JC. Glucose, insulin and myocardial ischaemia. Curr. Opin. Clin. Nutr. Metab. Care9, 131–139 (2006).